Keri Jolly

Keri Jolly is an accomplished professional in medical writing with extensive experience across various esteemed organizations. Currently serving as the Director of Medical Writing at RAPT Therapeutics since September 2023, Keri has held significant roles such as Principal Medical Writer at GLOBAL and various leadership positions at Genmab, including Director and Team Lead for Medical Writing. Previous experience includes serving as a Principal Medical Writing Scientist in Oncology at The Janssen Pharmaceutical Companies of Johnson & Johnson and an Adjunct Instructor in Scientific and Technical Writing at the University of Cincinnati. Keri’s career began at Medpace as a Medical Writer, and includes roles at Merck, PAREXEL, and GSW, a Syneos Health Company. Keri holds a Master of Arts in Professional Writing and Editing from the University of Cincinnati and a Bachelor of Arts in English Language and Literature from Wright State University.